Jean-Yves Delattre
Journal of Clinical Oncology · 2001–2016
A researcher in the Science corpus: 8 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Papers from Jean-Yves Delattre's perspective
Ordered by how strongly the researchers Jean-Yves Delattre trusts endorse each paper. Same corpus, a different order for every researcher.
- Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. (Brain : a journal of neurology)
- Preoperative staging of non-small-cell lung cancer with positron-emission tomography. (New England Journal of Medicine)
- Applied Logistic Regression (Technometrics)
- Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 (Nature Genetics)
- Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. (Brain : a journal of neurology)
- Integrated network analysis platform for protein-protein interactions (Nature Methods)
- A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer (Nature Genetics)
- Cohort profile: 1958 British birth cohort (National Child Development Study). (International Journal of Epidemiology)
- Birth weight and risk of type 2 diabetes: a systematic review. (Journal of the American Medical Association (JAMA))
- The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. (Archives of Internal Medicine)
Their papers
- Clinical trial of blood-brain barrier disruption by pulsed ultrasound (2016) — 675 citations
- Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. (2013) — 1,120 citations
- Genome-wide association study identifies five susceptibility loci for glioma (2009) — 810 citations
- Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. (2009) — 973 citations
- Radiotherapy for glioblastoma in the elderly. (2007) — 797 citations
- Recommended diagnostic criteria for paraneoplastic neurological syndromes (2004) — 1,464 citations
- Primary brain tumours in adults. (2003) — 1,845 citations
- Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. (2001) — 896 citations